Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 06/23/2025 3:20:56 PM
Board Marks: 278
Posts Today: 0
Board Views Today: 677
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
49737
Daubers it's known we are waiting on BTD
smokenhot
10/11/2018 12:43:59 PM
49736
Agree that we have raised $ and should at least
(2)
zdubble17
10/11/2018 12:43:12 PM
49735
I go agree. Ive now added over 60K shares
(1)
DaubersUP
10/11/2018 12:36:59 PM
49734
DaubersUP even at 16 million shares, that is only
(1)
zdubble17
10/11/2018 12:14:59 PM
49733
Alan. We need a deal or some kind of promising
(1)
DaubersUP
10/11/2018 12:06:00 PM
49732
Volume was around 500k but has flatlined for
Drano
10/11/2018 11:39:30 AM
49731
At 11:30 or two hours into the trading day volume
AlanC
10/11/2018 11:33:54 AM
49730
I would buy the .17's and consider yourself
(3)
AlanC
10/11/2018 9:57:08 AM
49729
The financing deal put my solvency concerns to
(1)
Squar
10/11/2018 9:53:55 AM
49728
Convinced me to pick up a bit more here Zdub.
Squar
10/11/2018 9:51:30 AM
49727
Good point. I have always felt that as painful as
(4)
Loose Lips
10/11/2018 9:50:53 AM
49726
It is what it is.
Kelt
10/11/2018 9:16:58 AM
49725
Sub penny thoughts are a bunch of nonsense. That
scgmck1
10/11/2018 8:59:45 AM
49724
I think what cracks me up is that this company
(11)
zdubble17
10/11/2018 8:50:52 AM
49723
yeah that will show the crooks. I got my sub
(2)
Jimmyboy
10/11/2018 8:49:04 AM
49722
If they are foolish enough do that, they will
(2)
scgmck1
10/11/2018 8:36:33 AM
49721
Really? Squar don't show your motive that easy.
zdubble17
10/11/2018 8:28:11 AM
49720
Anyone have a guess on trading? Are 0.17s the buy
(2)
Squar
10/11/2018 7:58:02 AM
49719
Priority review accompanying BTD for B-OM - yes.
(1)
Squar
10/10/2018 10:13:29 PM
49718
Included in it is "Material threat medical
(1)
Squar
10/10/2018 10:08:50 PM
49717
DaubersUp in the Swamp had a good post. Yes there
(6)
Trading Pro Broker
10/10/2018 8:55:06 PM
49716
Priority Review could/would be used in the
Kelt
10/10/2018 8:49:09 PM
49715
This is the list of criteria for a drug to meet
(2)
Kelt
10/10/2018 8:43:51 PM
49714
42% marked today and this does not include the
(1)
AlanC
10/10/2018 5:46:54 PM
49713
PRV is usually awarded for Orphan Drug
(1)
Squar
10/10/2018 5:35:10 PM
49712
IPIX pre market (t trades) today .. 09:29:22 0.20
(2)
4kids
10/10/2018 5:22:28 PM
49711
That is what I think as well.
Trading Pro Broker
10/10/2018 4:12:43 PM
49710
Another thought is that in order to secure the
(4)
Kelt
10/10/2018 4:10:09 PM
49709
Another good resource regarding PRV.
scgmck1
10/10/2018 3:31:49 PM
49708
"When seeking approval for a drug, manufacturers
(1)
Drano
10/10/2018 2:06:25 PM
49707
Drano,DoubleJ123 or any long term member here
(3)
Kelt
10/10/2018 1:58:10 PM
49706
I bet BTD was submitted when term sheet was
(4)
smokenhot
10/10/2018 1:54:09 PM
49705
The FDA will respond in 14 days for Type B (EOP)
(4)
sox0407
10/10/2018 1:49:56 PM
49704
The way the market loks some would think the sky
(3)
BooDog
10/10/2018 1:36:19 PM
49702
Trading just dried up. No trades for quite a
Drano
10/10/2018 1:06:08 PM
49701
With the position you're amassing in IPIX, pretty
Drano
10/10/2018 12:48:05 PM
49700
One thing I have noticed is that Leo and Art just
(4)
Chemdeps
10/10/2018 12:34:05 PM
49699
Very well could be Alan. Certainly putting the
(1)
BooDog
10/10/2018 12:17:12 PM
49698
That's a good point. It could be that someone is
(2)
Drano
10/10/2018 12:03:50 PM
49697
I just want to speculate a bit...maybe this
(3)
doubleJ23
10/10/2018 12:00:49 PM
49696
I think Leo is working a carefully crafted plan
(4)
AlanC
10/10/2018 11:53:03 AM
49695
We know the "Level 2" is not accurate. But
(2)
Drano
10/10/2018 11:48:00 AM
49694
Here's the Edgar (gov) link directly to the 8-K
Drano
10/10/2018 11:39:32 AM
49693
That sounds right to me. I have to think Co.
doubleJ23
10/10/2018 11:31:47 AM
49692
I bet our new partner will be sitting at that
(2)
smokenhot
10/10/2018 11:20:36 AM
49691
I provided a link, you can find it on company
doubleJ23
10/10/2018 11:19:00 AM
49690
Order filled! I welcome myself to the semi-big
(3)
Chemdeps
10/10/2018 11:18:47 AM
49689
Where was that? Please
DaubersUP
10/10/2018 11:17:28 AM
49688
Good find, doubleJ23. I'm not sure if I'm
Drano
10/10/2018 11:15:18 AM
49687
End of phase 2 meeting filed with FDA On October
(9)
doubleJ23
10/10/2018 11:12:29 AM
Newer
Older
Recent Articles
Unlocking Bitcoin's Potential: Galaxy Digital's Investment in Function
Trianz Unveils Groundbreaking Solutions at AWS Summit NYC 2025
Unlocking the Future: The Role of Trust in AI Advancement
Sobi Reports Q2 2025: Impressive Growth and Future Outlook
Sobi Reports Robust Performance in Q2 2025 Financials
Explore CJB Crypto's Innovative Green Mining Solutions
Join Tetragon Financial Group Limited for Upcoming Investor Call
Synovus Financial Earnings Expectations and Analyst Insights
Exploring Growth in the Projection Mapping Industry Through 2032
ICG Achieves Strong Growth with $123bn in Q1 Trading
Hofseth BioCare's ProGo® Triumphs at NutraIngredients Awards
IMCD Strengthens Leadership with New Executive Appointments
Nilörn Group Sees Mixed Financial Results for Q2 2025
Kenmare Resources Q2 2025 Production Update Highlights
Foresight Group's Strategic Share Buyback Initiative Explained
Caledonia Mining Reports Record Gold Production in Q2 2025
Stellantis Shifts Focus Away from Hydrogen Fuel Cell Development
Bitget Expands Token Offerings with Eclipse Listing and Rewards
Hofseth BioCare's ProGo® Earns Top Honors for Healthy Aging
Leadership Changes at IMCD to Enhance Global Operations
Kenmare Resources Reports Solid Production Results for 2025
ICG's Q1 Performance Review: Insights on Fundraising Growth
Nilörn Reports Insights from Q2 2025 Business Performance
Tetragon Financial Group: Upcoming Investor Call Insights
Xlence Unveils Trading Central Suite for Enhanced Trading Success
Innovative Global Healthcare Challenge Spotlights Emerging Startups
Elevating In-Car Entertainment: LG's webOS in New Kia Models
Experience Premium In-Car Entertainment with LG and Kia
ESET PROTECT Complete: Leaders in Cybersecurity Solutions 2025
Richemont Achieves Strong Growth in Q1 Sales Performance
Economist Peter Schiff Forecasts Market Reaction to Trump’s Tariffs
Nuwellis Achieves Significant Growth with New Patent Approval
Alm. Brand Group Reports Impressive Q2 Financial Results
Ocuco Faces Scrutiny After Massive Data Breach Affecting Patients
London Properties, Inc. Faces Scrutiny Over Data Breach
Investigation into ACCU Reference Medical Lab for Data Breach
Innovative Cybersecurity Solutions Earn Penta Recognition
ESET PROTECT Complete: The Future of Malware Protection
Promising Q2 Results: Alm. Brand Group's Solid Performance Overview
DNO ASA Temporarily Halts Operations Amidst Unexpected Incidents
Bitget Wallet Launches Weekly Staking Event with PUMP Tokens
ASML Reports Strong Q2 Performance with €7.7B in Sales
Borregaard ASA Achieves Significant Growth in 2nd Quarter
Ontex Revises 2025 Outlook Amid Falling Revenues and Margins
Aker ASA's Robust Financial Performance in 2025 Revealed
Market Watch: Inflation Raises Eyebrows as Fed Adjustments Loom
Argo Appoints Wilbert Landry to Boost Board Strength
ASML's Impressive Q2 Results Showcase Strong Growth Outlook
Sanofi's Innovative Gene Therapy Receives Fast Track Status
Ontex's Q1 Report: Navigating Market Challenges with Resilience